ChemicalBook > Product Catalog >API >Antibiotics >Cephalosporins Drugs >LF163892 MONOHYDRATE

LF163892 MONOHYDRATE

LF163892 MONOHYDRATE Structure
CAS No.
76470-66-1
Chemical Name:
LF163892 MONOHYDRATE
Synonyms
Lorabid;LOEACARBEF;LORACARBEF;LF163892 MONOHYDRATE;LORACARBEF MONOHYDRATE;LF163892 MONOHYDRATE USP/EP/BP;3-Chloro-7β-[[(R)-aminophenylacetyl]amino]-1-carbacepham-3-ene-4-carboxylic acid;(6R)-7α-[[(R)-Aminophenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,6β)-7α-[[(R)-Aminophenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7S)-7-[[(2R)-2-AMino-2-phenylacetyl]aMino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
CBNumber:
CB7330045
Molecular Formula:
C16H16ClN3O4
Molecular Weight:
349.77
MOL File:
76470-66-1.mol
Modify Date:
2023/4/26 16:55:04

LF163892 MONOHYDRATE Properties

Melting point >196°C (dec.)
Boiling point 662.2±55.0 °C(Predicted)
Density 1.52±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer, Under inert atmosphere
solubility Aqueous Acid (slightly)
pka 3.10±0.40(Predicted)
form Solid
color White to Off-White
BCS Class 2

LF163892 MONOHYDRATE Chemical Properties,Uses,Production

Description

Loracarbef is a synthetic C-5 “carba” analogue of cefaclor. The smaller methylene moiety (as compared to sulfur) would be expected to make loracarbef more reactive/potent, and this seems to be the case. It is more stable chemically, however, and this adds to its virtues.

Uses

An antibiotic, a synthetic carbacephem analogue of cefaclor, and is more stable chemically.

Definition

ChEBI: A synthetic "carba" analogue of cefaclor, with carbon replacing sulfur at position 1. Used to treat a wide range of infections caused by both gram-positive and gram-negative bacteria.

Antimicrobial activity

An oral carbacephem, with carbon replacing sulfur in the fused ring structure. Its structure and properties are otherwise closely related to those of cefaclor, but it has improved chemical stability. Activity and stability to β-lactamases correspond closely to those of cefaclor.
It is almost completely absorbed by the oral route, but food delays absorption. A 500 mg oral dose achieves a serum concentration of around 16 mg/L after 1.3 h. Adequate concentrations are achieved for the treatment of upper respiratory tract infection. Sputum concentrations have been found to be around 2% of the corresponding plasma level. The plasma half-life is about 1 h and protein binding is 25%. Most of the dose is excreted unchanged in the urine, 60% within 12 h. The elimination half-life is increased in patients with impaired renal function. Probenecid delays excretion.
Diarrhea is the most prominent side effect, occurring in about 4% of patients. Other gastrointestinal upsets are also reported. It has been used for the oral treatment of upper respiratory tract infection, skin and soft-tissue infections, and uncomplicated urinary tract infection caused by sensitive organisms, but is not widely available.

Clinical Use

Loracarbef (Lorabid) is the first of a series of carbacephemsprepared by total synthesis to be introduced. Carbacephemsare isosteres of the cephalosporin (or △ 3-cephem) antibioticsin which the 1-sulfur atom has been replaced by a methylene(CH2) group. Loracarbef is isosteric with cefaclor and hassimilar pharmacokinetic and microbiological properties.Thus, the antibacterial spectrum of activity resembles thatof cefaclor, but it has somewhat greater potency againstH. influenzae and M. catarrhalis, including β-lactamase–producing strains. Unlike cefaclor, which undergoes degradationin human serum, loracarbef is chemically stable inplasma. It is absorbed well orally. Oral absorption is delayedby food. The half-life in plasma is about 1 hour.

Side effects

Diarrhea is the most common adverse effect with loracarbef and, along with certain other adverse effects, is seen more frequently with children, so this lessens enthusiasm for the drug in patients younger than 12 years.

LF163892 MONOHYDRATE Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 35)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29824 58 Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 8444 58 Inquiry
AFINE CHEMICALS LIMITED +86-0571-85134551 China 15395 58 Inquiry
Hangzhou MolCore BioPharmatech Co.,Ltd. +86-057181025280; +8617767106207 China 49739 58 Inquiry
Shaanxi Xianhe Biotech Co., Ltd +8617709210191 China 465 58 Inquiry
Guangzhou PI PI Biotech Inc 020-81716320 +86-13602409664 China 3635 55 Inquiry
BOC Sciences 1-631-485-4226; 16314854226 United States 14059 65 Inquiry
MedChemExpress 021-58955995 United States 6398 58 Inquiry
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973186 4009686088 China 18352 68 Inquiry
Waterstone Technology, LLC 317 644 0862 United States 6801 30 Inquiry

76470-66-1(LF163892 MONOHYDRATE)Related Search:

LORACARBEF MONOHYDRATE LOEACARBEF (6R)-7α-[[(R)-Aminophenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,6β)-7α-[[(R)-Aminophenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 3-Chloro-7β-[[(R)-aminophenylacetyl]amino]-1-carbacepham-3-ene-4-carboxylic acid (6R,7S)-7-[[(2R)-2-AMino-2-phenylacetyl]aMino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Lorabid 1-Azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-aMino-2-phenylacetyl]aMino]-3-chloro-8-oxo-, (6R,7S)- LF163892 MONOHYDRATE LORACARBEF (6R,7S)-7-{[(2R)-2-Ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, monohydrate LF163892 MONOHYDRATE USP/EP/BP 76470-66-1 Amines Drug Analogues Intermediates & Fine Chemicals Pharmaceuticals